alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2019363EN.01000702.xml

| 28.10.2019 | EN | Official Journal of the European Union | C 363/7 |
| --- | --- | --- | --- |

28.10.2019

EN

Official Journal of the European Union

C 363/7

---

Request for a preliminary ruling from the Tribunal Superior de Justicia de Castilla-La Mancha (Spain) lodged on 25 July 2019 — MO v Subdelegación del Gobierno en Toledo

(Case C-568/19)

(2019/C 363/13)

Language of the case: Spanish

Referring court

Tribunal Superior de Justicia de Castilla-La Mancha

Parties to the main proceedings

Applicant: MO

Defendant: Subdelegación del Gobierno en Toledo

Question referred

Whether an interpretation of the judgment of the Court of Justice of 23 April 2015 (Case C-38/14, Zaizoune) (1) as meaning the Spanish authorities and courts can directly apply Directive 2008/115/EC (2)
  to the detriment of the third-country national, thereby ignoring and disapplying more advantageous national penalty provisions, aggravating that national’s liability to a penalty and possibly disregarding the principle that criminal penalties must be defined by law, is compatible with the case-law of the Court of Justice on the limits on the direct effect of directives, and should the fact that the Spanish legislation is not in conformity with that directive be resolved not in that way but by legislative reform or by the remedies provided by EU law whereby a State can be required properly to transpose directives.

---

(1)  Judgment of 23 April 2015, Zaizoune (C-38/14, EU:C:2015:260).

(2)  Directive 2008/115/EC of the European Parliament and of the Council of 16 December 2008 on common standards and procedures in Member States for returning illegally staying third-country nationals (OJ 2008 L 348, p. 98).

---
* Pursuant to 5TH CIR. R. 47.5, the court has determined

that this opinion should not be published and is not precedent

except under the limited circumstances set forth in 5TH CIR.

R. 47.5.4.

UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

 

No. 00-10639

Summary Calendar

 

RICKIE LYNN GRAVES,

Petitioner-Appellant,

versus

GARY L. JOHNSON, DIRECTOR, 

TEXAS DEPARTMENT OF CRIMINAL JUSTICE,

INSTITUTIONAL DIVISION,

Respondent-Appellee.

 

Appeal from the United States District Court

for the Northern District of Texas

(5:00-MC-19-C)

 

November 21, 2000

Before HIGGINBOTHAM, WIENER, and BARKSDALE, Circuit Judges.

PER CURIAM:*

Rickie Lynn Graves, Texas prisoner # 645074, seeks a

certificate of appealability (COA) to appeal the district court’s

denial of his motion for leave to file a 28 U.S.C. § 2254

application. Graves had previously been sanctioned by a 29 August

1994 order prohibiting him from filing any lawsuits in the Northern

District of Texas without first obtaining permission of a district

judge.
2

The district court denied Graves’ motion, stating that he had

failed to show cause why the sanctions should be lifted and that

his proposed 28 U.S.C. § 2254 application would be time-barred

pursuant to 28 U.S.C. § 2244(d).

Because Graves has failed to show on appeal why the sanctions

order should not apply, we uphold the sanctions order and DENY his

request for a COA.

COA DENIED
[No. 10196.

Department Two.

June 11, 1912.]

#### The State of Washington, *Respondent,*v. Harry A. Lake, Appellant.1

Appeal from a judgment of the superior court for King county, Ronald, J., entered October 7, 1911, upon a trial and conviction of false registration.

Reversed.

*Gill, Hoyt & Frye*and *R. L. Blewett,*for appellant.

1

 Reported in 124 Pac. 1135.

Per Ctjriam.

Defendant was charged with the crime of false and fraudulent registration, and appeals from a judgment entered upon a verdict of guilty. The error alleged is the insufficiency of the information. The case is similar to *State v. Ross,*66 Wash. 138, 119 Pac. 20, affirmed by the court on rehearing *en bane (Id,,*p. 141, 122 Pac. 8), and to *State v. Cohen,*67 Wash. 618, 700, 122 Pac. 9, 10, and for the reasons' there given the judgment is reversed, and the cause remanded with instructions to dismiss.
Exhibit 32.2

THANKSGIVING COFFEE COMPANY, INC.

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Thanksgiving Coffee Company, Inc. (the Company) on Form 10-K for the year ended December 31,
2009 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, the undersigned President of the Company hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:



| | (i) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (ii) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods
presented therein.
| | ---- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



/s/ Joan KatzeffPresident March 31, 2010
```

Exhibit 10.23

[GenoMed letterhead]

April 18, 2003

Dr. Jason Moore
Program in Human Genetics
Department of Molecular Physiology and Biophysics
519 Light Hall
Vanderbilt University Medical School
Nashville, Tennessee  37232-0700

Dear Jason,

At a special meeting of the board of directors of GenoMed, Inc. held on December
13, 2002, the board unanimously agreed to issue you nonqualified stock options
in consideration of your service to the corporation as a member of the
Scientific Advisory Board (SAB). These options are offered by the corporation as
an alternative to the outright gift of shares granted to you by your SAB
contract. Please consult with you tax attorney whether you would like to receive
the options or the gift of shares outright, and please write me by return mail
which is your choice. If I do not hear anything from you, I will assume that you
have elected to receive stock options rather than the gift of shares outright.

These stock options, in a form to be approved by the attorneys for the
corporation, are exercisable for the number of shares, and on the terms
described below:

Number of shares: one hundred thousand (100,000)

Exercise price: the closing bid price of the stock on January 16, 2003, the one
year anniversary date of the execution of your SAB contract, which was $0.012.

Time to exercise the option: 2 years from the date of issuance, i.e. until
January 16, 2005.

Please let me convey my own and the board's appreciation for your help during
this past year. (Please also forgive the tardiness of this letter.) I look
forward to working with you as our company grows.

Yours sincerely,

/s David W. Moskowitz
David W. Moskowitz
CMO, CEO, and Chairman

4560 Clayton Avenue    St. Louis, MO 63110  tel 314-977-0115  fax 314-977-0042
www.genomedics.com
```
# C_2020262EN.01003803.xml

| 10.8.2020 | EN | Official Journal of the European Union | C 262/38 |
| --- | --- | --- | --- |

10.8.2020

EN

Official Journal of the European Union

C 262/38

---

Order of the General Court of 4 June 2020 — UPL Europe and Aceto Agricultural Chemicals v Commission

(Case T-612/19) (1)

(2020/C 262/53)

Language of the case: English

The President of the Seventh Chamber has ordered that the case be removed from the register.

---

(1)  OJ C 399, 25.11.2019.

---
Letter Agreement



 Exhibit 10.3 
 

 
 December 4, 2009 
 Harleysville National Corporation 
 483 Main Street 
 Harleysville, Pennsylvania 19438 
 Gentlemen:

  

	 	Re:	Additional Loans 

 We refer to
the Promissory Note issued by you to us today in the original principal amount of $35,000,000 (the “Note”). All capitalized terms used but not defined in this letter shall have their meanings set forth in the Note. 
 This is to confirm our agreement with you that we will, prior to the termination of the Merger Agreement, loan you up to an additional
Fifteen Million Dollars ($15,000,000) (such amount, the “Additional Commitment”) (for a potential aggregate total loan of Fifty Million Dollars ($50,000,000)) on exactly the same terms as those contained in the Note to the extent you need
such additional funds in order to maintain the capital ratios of Harleysville National Bank and Trust Company at levels at least equal to those of a “Well Capitalized” (as defined in 12 C.F.R. Section 6.4) bank, without giving effect
to any charges taken at our request pursuant to Section 6.11 of the Merger Agreement, or to avoid being so deemed by the Federal Deposit Insurance Corporation, the Office of the Comptroller of the Currency or any other federal or state banking
regulator. 
 Any borrowing made by you pursuant to this letter (such borrowing an “Additional Borrowing”) shall
reduce the Additional Commitment by the amount of such Additional Borrowing. For the avoidance of doubt, the Additional Commitment shall remain available to you until the aggregate amount of all Additional Borrowings total Fifteen Million Dollars
($15,000,000). 







 Harleysville National Corporation 
 December 4, 2009 
 Page 2 
 If you are in agreement with the terms of this letter, please so indicate by dating and signing a copy of this letter in the place indicated
below and returning it to us. The additional copy of this letter is for your records. 
  

			
	FIRST NIAGARA FINANCIAL GROUP, INC.
		
	By:	 	/s/ Michael W. Harrington
		 	 Name: Michael W. Harrington
 Title: CFO



 The above terms are accepted and agreed to 
 this 4th day of December, 2009 
  

			
	HARLEYSVILLE NATIONAL CORPORATION
		
	By:	 	/s/ Paul D. Geraghty
		 	 Name: Paul D. Geraghty
 Title: President & CEO
SUPREME COURT OF THE STATE OF NEW YORK

Appellate Division, Fourth Judicial Department

913 

KA 09-02094 

PRESENT: CENTRA, J.P., CARNI, SCONIERS, AND WHALEN, JJ.

 

 

THE PEOPLE OF THE STATE OF NEW YORK, RESPONDENT, 

V ORDER

JOHNNY B. BIVINS, SR., DEFENDANT-APPELLANT.

 

SHIRLEY A. GORMAN, BROCKPORT, FOR DEFENDANT-APPELLANT. 

ERIC T. SCHNEIDERMAN, ATTORNEY GENERAL, ALBANY (HANNAH STITH LONG OF

COUNSEL), FOR RESPONDENT. 

 

Appeal from a judgment of the Supreme Court, Monroe County

(Francis A. Affronti, J.), rendered June 18, 2009. The judgment

convicted defendant, upon his plea of guilty, of attempted criminal

possession of a controlled substance in the second degree. 

Now, upon reading and filing the stipulation of discontinuance

signed by defendant on July 23, 2014 and by the attorneys for the

parties on August 1 and 5, 2014,

It is hereby ORDERED that said appeal is unanimously dismissed 

upon stipulation.

Entered: September 26, 2014 Frances E. Cafarell

Clerk of the Court
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 997 Introduced in Senate (IS)]

112th CONGRESS
  1st Session
                                 S. 997

 To authorize the Secretary of the Interior to extend a water contract 
   between the United States and the East Bench Irrigation District.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 12, 2011

  Mr. Tester introduced the following bill; which was read twice and 
       referred to the Committee on Energy and Natural Resources

_______________________________________________________________________

                                 A BILL

 
 To authorize the Secretary of the Interior to extend a water contract 
   between the United States and the East Bench Irrigation District.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``East Bench Irrigation District Water 
Contract Extension Act''.

SEC. 2. AUTHORITY TO EXTEND WATER CONTRACT.

    The Secretary of the Interior may extend the contract for water 
services between the United States and the East Bench Irrigation 
District, numbered 14-06-600-3593, until the earlier of--
            (1) the date that is 4 years after the date on which the 
        contract would have expired if this Act had not been enacted; 
        or
            (2) the date on which a new long-term contract is executed 
        by the parties to the contract.
                                 <all>
```
[Federal Register Volume 86, Number 134 (Friday, July 16, 2021)]
[Notices]
[Page 37758]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-15120]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Neurodevelopment, Neurodegeneration, 
Neuroimmunology, Infections Diseases and Brain Tumors.
    Date: July 29, 2021.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Pat Manos, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5200, MSC 7846, Bethesda, MD 20892, 301-408-
9866, <a href="/cdn-cgi/l/email-protection#117c707f7e626170517262633f7f78793f767e67"><span class="__cf_email__" data-cfemail="f9949897968a8998b99a8a8bd7979091d79e968f">[email protected]</span></a>.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: July 12, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-15120 Filed 7-15-21; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
ex4_102new.htm


     

    
       

       

       

       

       

      Exhibit 4.102

       

      
 

      

      
        First
Floor, Block 3, The Oval, Shelbourne Road, Ballsbridge, Dublin 4,
Ireland.

        Tel:  +353
(0) 1 669 9020    Fax:  +353 (0) 1 669
9028

      

      October
12, 2009

       

      Dr. Joseph
Zakrzewski

       

      Dear
Joe

       

      I am
pleased to offer you the position of Special Advisor to the Board of Amarin
Corporation plc (“the
Company”).  This is deemed to be effective from September 15,
2009.

       

      As
Special Adviser, your role and responsibilities will be as from time to time
determined by the Board of Directors.

       

      In
consideration thereof, the Company will pay you a fee of $37,500 per calendar
quarter and will reimburse any travel and out of pocket expenses incurred by you
in the execution of your responsibilities.

       

      In
addition, the Board is pleased to offer you an option over 1,170,000 American
Depositary Shares (“ADSs”) to be granted on
January 1, 2010.  The per share purchase price of such grant will be
determined by reference to the closing price for Amarin ADSs on December 31,
2009 as determined by the closing price on the NASDAQ National
Market.

       

      Such
stock options will vest ratably as set forth below and are subject to the terms
of the Company’s Stock Option Plan (a copy of which is hereto
appended).

       

      
        	
                January
      1, 2010

              	
                25%

              
	
                January
      1, 2011

              	
                25%

              
	
                January
      1, 2012

              	
                25%

              
	
                January
      1, 2013

              	
                25%

              


      

      


      I would
also be very grateful if you could arrange to execute the draft Consulting
Contract provided previously.

       

      I trust
that these terms are satisfactory and I would be very grateful if you could
signify your approval and consent by return email.

       

      Very
truly yours,

       

      /s/ Thomas G. Lynch      

      THOMAS
G. LYNCH

      CHAIRMAN
OF THE BOARD

      


      OCTOBER
12, 2009

       

       

       

      
 

      I hereby
accept and agree to the terms set out above.

       

      /s/ Dr. Joseph
Zakrzewski      

      DR.
JOSEPH ZAKRZEWSKI

      


      OCTOBER
12, 2009
```

Exhibit 10.24

[GenoMed letterhead]

January 9, 2003

Dr. Scott Williams
Meharry Medical College
Department of Microbiology
1005 D.B. Todd Blvd.
Nashville, TN  37208

Dear Scott,

At a special meeting of the board of directors of GenoMed, Inc. held on December
13, 2002, the board unanimously agreed to issue you nonqualified stock options
in consideration of your service to the corporation as a member of the
Scientific Advisory Board (SAB), as per your contract. These stock options, in a
form to be approved by the attorneys for the corporation, are exercisable for
the number of shares, and on the price and terms described below:

Number of shares: one hundred thousand (100,000)

Exercise price:  the closing bid price of the stock on November 2, 2002, the one
year  anniversary  date of the execution of your SAB contract,  which was $0.025
(2.5 cents)

Time to exercise the option: 2 years from the date of issuance, i.e. until
November 2, 2004.

Please let me convey my own and the board's appreciation for a job well done.
(Please also forgive the tardiness of this letter.) I look forward to working
with you as our company grows.

Yours sincerely,

/s Dave Moskowitz
David W. Moskowitz
CMO, CEO, and Chairman

4560 Clayton Avenue    St. Louis, MO 63110  tel 314-977-0115  fax 314-977-0042
www.genomedics.com
```
Exhibit
32.1




Certification Pursuant to 18
U.S.C. Section 1350, as Adopted Pursuant to


Section 906 of
Sarbanes-Oxley Act of 2002





I, George E. Daddis Jr., the Principal
Executive Officer of WorldGate Communications, Inc., hereby certify, pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that the Form 10-Q of WorldGate
Communications, Inc., for the quarterly period ended March 31, 2010, which this
certification accompanies, fully complies with requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)) and
information contained in the Form 10-Q for the quarter ended March 31, 2010
fairly presents, in all material respects, the financial condition and results
of operations of WorldGate Communications, Inc.





A signed original of this written
statement required by Section 906 has been provided to WorldGate and will be
retained by WorldGate and furnished to the Securities and Exchange Commission or
its staff upon request.





Dated:  May
      12, 2010
            
            /s/  George
      E. Daddis Jr.George
      E. Daddis Jr.Chief
      Executive Officer(Principal
      Executive Officer)
# C_2020054EN.01003201.xml

| 17.2.2020 | EN | Official Journal of the European Union | C 54/32 |
| --- | --- | --- | --- |

17.2.2020

EN

Official Journal of the European Union

C 54/32

---

Request for a preliminary ruling from the Tribunal Superior de Justicia de Cataluña (Spain) lodged on 20 November 2019 — Instituto Nacional de la Seguridad Social (INSS) v BT

(Case C-843/19)

(2020/C 54/34)

Language of the case: Spanish

Referring court

Tribunal Superior de Justicia de Cataluña

Parties to the main proceedings

Appellant: Instituto Nacional de la Seguridad Social (INSS)

Respondent: BT

Question referred

Does EU law preclude a provision of national law such as Article 208(1)(c) of the 2015 Ley General de la Seguridad Social (General Law on Social Security), which stipulates that, in order for anyone enrolled in the General Scheme to be able to take voluntary early retirement, the pension payable, calculated in the standard way without any minimum pension supplement, must be at least as much as the minimum pension, inasmuch as it indirectly discriminates against women enrolled in the General Scheme, since it affects a far greater number of women than men?

---
Exhibit 32.1
 
 CERTIFICATION
 PURSUANT TO
 18 U.S.C. SECTION 1350,
 AS ADOPTED PURSUANT TO
 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 I, Syed Zaidi, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of NeoMagic Corporation on Form 10-Q for the quarterly period ended October 31, 2010 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report fairly presents in all material respects the financial condition and results of operations of NeoMagic Corporation.
 
 Date: December 9, 2010
 
 By:

/s/ Syed ZaidiName:

SYED ZAIDITitle:

President and Chief Executive Officer
_______________________________________ __ 

### Michigan Supreme Court 

# Order

Lansing, Michigan



## September 9, 2008 Clifford W. Taylor, Chief Justice


## 135842 Michael F. Cavanag h Elizabeth A. Weave r Marilyn Kell y Maura D. Corriga n 

## PEOPLE OF THE STATE OF MICHIGAN, Plaintiff-Appellee, Robert P. Young, Jr. Stephen J. Markman, J ustices



## v SC: 135842 COA: 279206 Berrien CC: 2002-400252-FC RAYMOND LEE KYLE, Defendant-Appellant.

________________ _________________________/

On order of the Court, the application for leave to appeal the January 11, 2008 order of the Court of Appeals is considered, and it is DENIED, because the defendant has failed to meet the burden of establishi ng entitlement to relief under MCR 6.508(D).

s0828 I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

September 9, 2008

Clerk
Exhibit 32.2
 CERTIFICATION
 PURSUANT TO
 18 U.S.C. SECTION 1350,
 AS ADOPTED PURSUANT TO
 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 I, Charlotte A. Willson, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of NeoMagic Corporation on Form 10-Q for the quarterly period ended October 31, 2010 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report fairly presents in all material respects the financial condition and results of operations of NeoMagic Corporation.
 Date December 9, 2010
 By:

/s/ Charlotte A. WillsonName:

CHARLOTTE A. WILLSONTitle:

Vice President, Finance and Administration

Principal Financial Officer